Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment-Related Adverse Events From the CheckMate 040 Study
纳武利尤单抗治疗晚期肝细胞癌：CheckMate 040 研究的安全性概况和部分治疗相关不良事件
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0591
Julien, Karen; Leung, Hiu Tung; Fuertes, Carmen; Mori, Megumi; Wang, Miao-Jen; Teo, Jocelyn; Weiss, Lisa; Hamilton, Sara; DiFebo, Holly; Noh, Yoon Jin; Galway, Aralee; Koh, Jane; Brutcher, Edith; Zhao, Huanyu; Shen, Yun; Tschaika, Marina; To, Yue-Yun
